Search

Showing results for: AUTHOR - Lan, P

Found: 5 results

BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphoma Blood Advances - 2020-10-13 Sejic, N; George, LC; Tierney, RJ; Chang, C; Kondrashova, O; MacKinnon, RN; Lan, P; Bell, AI; Lessene, G; Long, HM; Strasser, A; Shannon-Lowe, C; Kelly, GL
Link to Open Access at Publisher's Site Download PDF
Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma Oncogene - 2020-02 Dengler, MA; Teh, CE; Thijssen, R; Gangoda, L; Lan, P; Herold, MJ; Gray, DH; Kelly, GL; Roberts, AW; Adams, JM
Link to Publisher's Version Download Author Manuscript
BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines Blood Advances - 2020-01-28 Diepstraten, ST; Chang, C; Tai, L; Gong, JN; Lan, P; Dowell, AC; Taylor, GS; Strasser, A; Kelly, GL
Link to Open Access at Publisher's Site
Combining BH3-Mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia Leukemia - 2018-09-10 Moujalled, DM; Pomilio, G; Ghiurau, C; Ivey, A; Salmon, J; Rijal, S; Macraild, S; Zhang, L; Teh, TC; Tiong, IS; Lan, P; Chanrion, M; Claperon, A; Rocchetti, F; Zichi, A; Kraus-Berthier, L; Wang, Y; Halilovic, E; Morris, E; Colland, F; Segal, D; Huang, D; Roberts, AW; Maragno, AL; Lessene, G; Geneste, O; Wei, AH
Link to Open Access at Publisher's Site
Conversion of Bim-BH3 from activator to inhibitor of Bak through structure-based design Molecular Cell - 2017-11-16 Brouwer, JM; Lan, P; Cowan, AD; Bernardini, JP; Birkinshaw, RW; van Delft, MF; Sleebs, BE; Robin, AY; Wardak, A; Tan, IK; Reljic, B; Lee, EF; Fairlie, WD; Call, MJ; Smith, BJ; Dewson, G; Lessene, G; Colman, PM; Czabotar, PE
Link to Publisher's Version

An error has occurred. This application may no longer respond until reloaded. Reload 🗙